Cargando…

Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study

PURPOSE: The prognosis for recipients with hepatocellular carcinoma (HCC) of salvage liver transplantation (SLT) versus those of primary liver transplantation (PLT) remains controversial. The objective of this study was to evaluate the clinical features and survival rate of SLT recipients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Pusen, Pu, Ying, Li, Hao, Shi, Baojie, Zheng, Shengnai, Zhong, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069219/
https://www.ncbi.nlm.nih.gov/pubmed/27818858
http://dx.doi.org/10.1186/s40064-016-3441-5
_version_ 1782460895630196736
author Wang, Pusen
Pu, Ying
Li, Hao
Shi, Baojie
Zheng, Shengnai
Zhong, Lin
author_facet Wang, Pusen
Pu, Ying
Li, Hao
Shi, Baojie
Zheng, Shengnai
Zhong, Lin
author_sort Wang, Pusen
collection PubMed
description PURPOSE: The prognosis for recipients with hepatocellular carcinoma (HCC) of salvage liver transplantation (SLT) versus those of primary liver transplantation (PLT) remains controversial. The objective of this study was to evaluate the clinical features and survival rate of SLT recipients. METHODS: Three hundred seventy-one patients with HCC transplanted at Shanghai General Hospital, China, between October 2001 and October 2011 were separated into PLT (n = 295) and SLT (n = 76) groups. Patient characteristics and survival curves were studied by univariate and multivariate analysis. A Milan criteria-stratified survival analysis was conducted. RESULTS: The proportions of reoperation (11.8 vs. 5.4 %, P = 0.047) and early postoperative mortality (11.8 vs. 4.7 %, P = 0.032) were higher in the SLT group than in the PLT group. Recurrence free survival (RFS) rate and overall survival (OS) rate had no statistically significant differences after stratification using Milan criteria between the PLT group and SLT group. Alphafetoprotein >400 ng/mL (P = 0.011), microscopic vascular invasion (MVI) (P < 0.001), tumor node metastasis (TNM) staging (P = 0.006), and out of Milan criteria (P < 0.001) were independent risk factors for RFS, while MVI (P < 0.001), TNM staging (P = 0.009), and out of Milan criteria (P = 0.003) were factors for OS. In the multivariate logistic regression analysis, HCC recurrence was associated with MVI (OR = 4.196 [2.538–6.936], P < 0.001), and out of Milan criteria (OR = 2.704 [1.643–4.451], P < 0.001). CONCLUSIONS: Our retrospective, single-center study demonstrated that SLT increases surgical difficulty; however, it has good post-transplantation OS and is a feasible alternative after HCC recurrence within Milan criteria.
format Online
Article
Text
id pubmed-5069219
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-50692192016-11-04 Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study Wang, Pusen Pu, Ying Li, Hao Shi, Baojie Zheng, Shengnai Zhong, Lin Springerplus Research PURPOSE: The prognosis for recipients with hepatocellular carcinoma (HCC) of salvage liver transplantation (SLT) versus those of primary liver transplantation (PLT) remains controversial. The objective of this study was to evaluate the clinical features and survival rate of SLT recipients. METHODS: Three hundred seventy-one patients with HCC transplanted at Shanghai General Hospital, China, between October 2001 and October 2011 were separated into PLT (n = 295) and SLT (n = 76) groups. Patient characteristics and survival curves were studied by univariate and multivariate analysis. A Milan criteria-stratified survival analysis was conducted. RESULTS: The proportions of reoperation (11.8 vs. 5.4 %, P = 0.047) and early postoperative mortality (11.8 vs. 4.7 %, P = 0.032) were higher in the SLT group than in the PLT group. Recurrence free survival (RFS) rate and overall survival (OS) rate had no statistically significant differences after stratification using Milan criteria between the PLT group and SLT group. Alphafetoprotein >400 ng/mL (P = 0.011), microscopic vascular invasion (MVI) (P < 0.001), tumor node metastasis (TNM) staging (P = 0.006), and out of Milan criteria (P < 0.001) were independent risk factors for RFS, while MVI (P < 0.001), TNM staging (P = 0.009), and out of Milan criteria (P = 0.003) were factors for OS. In the multivariate logistic regression analysis, HCC recurrence was associated with MVI (OR = 4.196 [2.538–6.936], P < 0.001), and out of Milan criteria (OR = 2.704 [1.643–4.451], P < 0.001). CONCLUSIONS: Our retrospective, single-center study demonstrated that SLT increases surgical difficulty; however, it has good post-transplantation OS and is a feasible alternative after HCC recurrence within Milan criteria. Springer International Publishing 2016-10-18 /pmc/articles/PMC5069219/ /pubmed/27818858 http://dx.doi.org/10.1186/s40064-016-3441-5 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Wang, Pusen
Pu, Ying
Li, Hao
Shi, Baojie
Zheng, Shengnai
Zhong, Lin
Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study
title Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study
title_full Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study
title_fullStr Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study
title_full_unstemmed Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study
title_short Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study
title_sort prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069219/
https://www.ncbi.nlm.nih.gov/pubmed/27818858
http://dx.doi.org/10.1186/s40064-016-3441-5
work_keys_str_mv AT wangpusen prognosisforrecipientswithhepatocellularcarcinomaofsalvagelivertransplantationversusthoseofprimarylivertransplantationaretrospectivesinglecenterstudy
AT puying prognosisforrecipientswithhepatocellularcarcinomaofsalvagelivertransplantationversusthoseofprimarylivertransplantationaretrospectivesinglecenterstudy
AT lihao prognosisforrecipientswithhepatocellularcarcinomaofsalvagelivertransplantationversusthoseofprimarylivertransplantationaretrospectivesinglecenterstudy
AT shibaojie prognosisforrecipientswithhepatocellularcarcinomaofsalvagelivertransplantationversusthoseofprimarylivertransplantationaretrospectivesinglecenterstudy
AT zhengshengnai prognosisforrecipientswithhepatocellularcarcinomaofsalvagelivertransplantationversusthoseofprimarylivertransplantationaretrospectivesinglecenterstudy
AT zhonglin prognosisforrecipientswithhepatocellularcarcinomaofsalvagelivertransplantationversusthoseofprimarylivertransplantationaretrospectivesinglecenterstudy